Gabify Raises Pre-Seed Funding to Advance AI-Driven Early Screening for Neurodevelopmental Disorders

Healthtech startup Gabify has raised $175,000 in a pre-seed funding round led by Inflection Point Ventures, marking an important step in its mission to revolutionize early screening and therapy management for children with speech and neurodevelopmental disorders. In addition, the company has secured ₹25 lakh under the Nidhi Seed Support Scheme from GHRTBI, further strengthening its innovation and research capabilities.

Founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, Gabify is building an AI-powered platform designed to identify and manage conditions such as autism and ADHD at an early stage. The startup aims to bridge the gap between early diagnosis and accessible therapy, an area that remains underserved in India and many parts of the world.

Gabify’s core offering is built on a dual AI system that combines voice and vision analysis. The platform evaluates speech patterns, facial expressions, and behavioural cues to generate insights that can help in early detection. What sets Gabify apart is its “human-in-the-loop” approach, ensuring that clinical experts remain involved in validating and supervising the AI-driven outcomes. This blend of technology and human expertise enhances both accuracy and reliability.

The funds raised will be strategically utilised for clinical validation, further development of its technology stack, and expansion of its team. These initiatives are crucial as Gabify prepares to scale its operations and strengthen its presence across multiple channels.

The startup has already demonstrated strong early traction, with its platform tested in over 35 preschools and daycare centres. It is currently being used by schools, hospitals, and clinics, showcasing its versatility and real-world applicability in diverse environments.

Gabify has also gained recognition within the startup ecosystem. It has been named among the top 10 startups under Anupam Mittal’s DreamDeal initiative and is part of Inflection Point Ventures’ IdeaSchool programme, both of which validate its potential and innovation in the healthtech space.

Looking ahead, Gabify has set an ambitious goal of reaching one million children by 2028 through a mix of B2B, B2C, and CSR-led channels. As awareness around early diagnosis continues to grow, Gabify is well-positioned to play a transformative role in improving outcomes for children with developmental challenges.